भारत सरकार ने बायोलॉजिकल-ई को 30 करोड़ रुपये का ऐडवांस पेमेंट करने का फैसला लिया है। बदले में कंपनी कोविड-19 वैक्सीन की 30 करोड़ डोज रिजर्व रखेगी। स्वास्थ्य मंत्रालय ने एक बयान में कहा कि यह सभी डोज अगस्त से दिसंबर 2021 के बीच बनाकर स्टॉक कर ली जाएंगी। ऐडवांस में वैक्सीन मैनुफैक्चरिंग के प्रस्ताव को वैक्सीन ऐडमिनिस्ट्रेशन पर बने नैशनल एक्सपर्ट ग्रुप (NEGVAC) ने जांचा है। आइए आप
While experts claim there is little indication that animals play a substantial role in the disease s spread to people, infections have been detected in a variety of species around the world.
3rd COVID-19 vaccine in India? Expert panel to decide on Russia s Sputnik V
Of around 20 coronavirus vaccines in several clinical and pre-clinical stages, Russia s Sputnik V may get SEC s nod first
BusinessToday.In | April 12, 2021 | Updated 12:02 IST
With a manufacturing capacity of 850 million doses in India, Sputnik V, if approved, will prove to be a major shot in the arm in the fight against coronavirus
India may get a third COVID-19 vaccine soon as the Subject Expert Committee (SEC) will meet on Monday, April 12, to consider Sputnik V application for emergency use authorisation (EUA) in India.
As more and more states flag shortages of coronavirus vaccine doses, the Centre has pressed the accelerator to expand vaccine production manifold.
| UPDATED: 13:20, Sun, Feb 21, 2021
Link copied Sign up for FREE now and never miss the top politics stories again
SUBSCRIBE Invalid email
When you subscribe we will use the information you provide to send you these newsletters. Sometimes they ll include recommendations for other related newsletters or services we offer. Our Privacy Notice explains more about how we use your data, and your rights. You can unsubscribe at any time.
AstraZeneca has committed to supply the EU with 80 million to 100 million doses of the much-needed COVID-19 vaccine by the end of 2021 s first quarter. But the EU Commission has been at loggerheads with the coronavirus jab supplier since January after it emerged AstraZeneca would fall short of its target by some 75 million jabs due to problems with production at plants in Europe. The EU has aimed to vaccinate at least 70 percent of its member states populations by the end of the summer.
A multi-ministerial meeting on Monday discussed various aspects of India's possible export of COVID-19 vaccines in view of requests from an increasing number of countries to procure the vaccines, people familiar with the development said.